Sam J. Lubner, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthDr. Lubner graduated from Princeton University, Princeton, NJ, with a BA in History in 1999, and the University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI with a MD, in 2003. His postgraduate internship and residency training in Internal Medicine was performed at Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, MO from 2003 to 2006, and a fellowship in Hematology/Oncology at University of Wisconsin Hospital and Clinics, Madison, WI.
Specialties
Clinics
UW School of Medicine and Public Health
| Department of Medicine |
Professional Certifications and Education
| Board Certification |
Medical Oncology
|
| Fellowship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Residency |
Barnes-Jewish Hospital, St. Louis, MO
|
| Internship |
Barnes-Jewish Hospital, St. Louis, MO
|
| Medical School |
University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI
|
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
PubMed Articles
-
Uboha NV Lubner SJ LoConte NK Mulkerin DL Eickhoff JC Deming DA
Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors. Invest New Drugs . 2020 Oct;38(5):1520-1525
[PubMed ID: 32253554]
-
Witt JS Kuczmarska-Haas A Lubner M Reeder SB Cho SY Minter R Weber S Ronnekleiv-Kelly S Abbott D LoConte N Mulkerin DL Lubner SJ Uboha NV Deming D Ritter MA Mohindra P Bassetti MF
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys . 2020 Sep 14;
[PubMed ID: 32942002]
-
Lou E Beg MS Bergsland E Eng C Khorana AA Kopetz S Lubner S Saltz L Shankaran V Zafar SY
Reply to S. Boutayeb et al. JCO Oncol Pract . 2020 Aug;16(8):525
[PubMed ID: 32574129]
-
Lou E Beg S Bergsland E Eng C Khorana A Kopetz S Lubner S Saltz L Shankaran V Zafar SY
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk. JCO Oncol Pract . 2020 Jul;16(7):383-388
[PubMed ID: 32352884]
-
Abou-Alfa GK Macarulla T Javle MM Kelley RK Lubner SJ Adeva J Cleary JM Catenacci DV Borad MJ Bridgewater J Harris WP Murphy AG Oh DY Whisenant J Lowery MA Goyal L Shroff RT El-Khoueiry AB Fan B Wu B Chamberlain CX Jiang L Gliser C Pandya SS Valle JW Zhu AX
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol . 2020 Jun;21(6):796-807
[PubMed ID: 32416072]
-
Cherukuri AR Lubner MG Zea R Hinshaw JL Lubner SJ Matkowskyj KA Foltz ML Pickhardt PJ
Tissue sampling in the era of precision medicine: comparison of percutaneous biopsies performed for clinical trials or tumor genomics versus routine clinical care. Abdom Radiol (NY) . 2019 Jun;44(6):2074-2080
[PubMed ID: 30032384]
-
Sahai V Catalano PJ Zalupski MM Lubner SJ Menge MR Nimeiri HS Munshi HG Benson AB 3rd O'Dwyer PJ
Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA Oncol . 2018 Dec 1;4(12):1707-1712
[PubMed ID: 30178032]
-
Kupfer SS Lubner S Coronel E Pickhardt PJ Tipping M Graffy P Keenan E Ross E Li T Weinberg DS
Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers. Cancer Med . 2018 Nov;7(11):5351-5358
[PubMed ID: 30338661]
-
Lubner S Feng Y Mulcahy M O'Dwyer P Giang GY Hinshaw JL Deming D Klein L Teitelbaum U Payne J Engstrom P Stella P Meropol N Benson A
E4206: AMG 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. Oncologist . 2018 Sep;23(9):1006-e104
[PubMed ID: 29853660]
-
Weinberg DS Pickhardt PJ Bruining DH Edwards K Fletcher JG Gollub MJ Keenan EM Kupfer SS Li T Lubner SJ Markowitz AJ Ross EA
Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance After Surgery. Gastroenterology . 2018 Mar;154(4):927-934.e4
[PubMed ID: 29174927]
-
Lubner MG Stabo N Lubner SJ Del Rio AM Song C Pickhardt PJ
Volumetric Versus Unidimensional Measures of Metastatic Colorectal Cancer in Assessing Disease Response. Clin Colorectal Cancer . 2017 Dec;16(4):324-333.e1
[PubMed ID: 28433601]
-
Pickhardt PJ Edwards K Bruining DH Gollub M Kupfer S Lubner SJ Kim DH Ross E Keenan E Weinberg DS
Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care. Dis Colon Rectum . 2017 Nov;60(11):1162-1167
[PubMed ID: 28991080]
-
Lubner SJ Uboha NV Deming DA
Primary and acquired resistance to biologic therapies in gastrointestinal cancers. J Gastrointest Oncol . 2017 Jun;8(3):499-512
[PubMed ID: 28736637]
-
Thomas MJ Bartlett HL Bassetti MF Lubner SJ Kirvassilis G Anagnostopoulos PV Maloney JD Macke RA
Minimally Invasive Esophagectomy in a Patient With Tetralogy of Fallot and Right-Sided Aortic Arch. Ann Thorac Surg . 2017 Jan;103(1):e77-e79
[PubMed ID: 28007281]
-
Sievers CK Kratz JD Zurbriggen LD LoConte NK Lubner SJ Uboha N Mulkerin D Matkowskyj KA Deming DA
The Multidisciplinary Management of Colorectal Cancer: Present and Future Paradigms. Clin Colon Rectal Surg . 2016 Sep;29(3):232-8
[PubMed ID: 27582648]
-
Jin N Lubner SJ Mulkerin DL Rajguru S Carmichael L Chen H Holen KD LoConte NK
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors. Oncologist . 2016 Jul;21(7):785-6
[PubMed ID: 27261467]
-
Deming DA Cavalcante LL Lubner SJ Mulkerin DL LoConte NK Eickhoff JC Kolesar JM Fioravanti S Greten TF Compton K Doyle AG Wilding G Duffy A Liu G
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer. Invest New Drugs . 2016 Apr;34(2):168-75
[PubMed ID: 26666244]
-
Deming D Uboha N Zafar SY Rosenberg S Bassetti M Glasgow S Borden EC Lubner S
Adjuvant Chemotherapy for Stage II Rectal Cancer. Semin Oncol . 2015 Dec;42(6):e99-107
[PubMed ID: 26615141]
-
Lubner MG Stabo N Lubner SJ del Rio AM Song C Halberg RB Pickhardt PJ
CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging . 2015 Oct;40(7):2331-7
[PubMed ID: 25968046]
-
Tran NH Cavalcante LL Lubner SJ Mulkerin DL LoConte NK Clipson L Matkowskyj KA Deming DA
Precision medicine in colorectal cancer: the molecular profile alters treatment strategies. Ther Adv Med Oncol . 2015 Sep;7(5):252-62
[PubMed ID: 26327923]